April 2021 Simoa® Publications:
Other Research Areas: Infectious Disease, Oncology, and Technology
Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study
Frithiof R, et al.
Clin Neurophysiol. 2021
COVID-19
Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients
Zonneveld R, et al.
J Clin Virol. 2021;139:104821
COVID-19
Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19
Geis T, et al.
Journal of Neurology. 2021
COVID-19
Development and validation of a triplex assay to study an antibody cocktail against Ebola virus in cynomolgus serum
Wang B, et al.
Bioanalysis. 2021
Infectious Disease
Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?
Flores J, et al.
Frontiers in Microbiology. 2021;12
Infectious Disease
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results
Advani R, et al.
Blood. 2021
Oncology
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Gangoso E, et al.
Cell. 2021
Oncology
Single Molecule Assay for Ultrasensitive Detection of Cathepsin B in Human Blood
Thangavelu B and Boutté AM
ACS Omega. 2021
Technology
April 2021 Simoa® Publications in Other Therapeutic Areas
